Used in biomedical research to detect and quantify intestinal fatty acid binding protein (iFABP) in biological samples such as serum, plasma, and tissue homogenates. This kit is particularly valuable in studies related to intestinal health and damage, as iFABP is released into the bloodstream upon injury to intestinal epithelial cells. It is widely applied in research on conditions like necrotizing enterocolitis, inflammatory bowel disease, celiac disease, and ischemia-reperfusion injury. The assay helps assess the extent of gut barrier dysfunction and monitor response to therapeutic interventions. Due to its high sensitivity and specificity, this ELISA kit supports both clinical research and preclinical studies in gastroenterology and immunology.